FEDERATED HERMES, INC.

Position in TYRA — Tyra Biosciences, Inc.

CIK 1056288 PITTSBURGH, PA

Position in TYRA

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$11,785

-$15,561 QoQ

Shares Held

369

-48.3% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.00%

of 13F equity value

Holder Rank

#145

of 169 holders

Holding Since

Mar 2023

14 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

FEDERATED HERMES, INC. holds $2,455,215,104 across 149 Biotechnology names. TYRA ranks #126 (0.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALNY	Alnylam Pharmaceuticals, Inc.	719,905	$216,713,000
2	RYTM	Rhythm Pharmaceuticals, Inc.	1,785,716	$198,268,046
3	REGN	Regeneron Pharmaceuticals, Inc.	256,884	$160,177,448
4	MRNA	Moderna, Inc.	1,794,778	$125,688,301
5	KYMR	Kymera Therapeutics, Inc.	749,398	$85,933,468
6	EYPT	EyePoint, Inc.	5,681,052	$81,239,042
7	ARGX	Argenx SE	87,288	$80,983,187
8	ZBIO	Zenas BioPharma, Inc.	3,116,805	$79,104,510

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$11,785	369	-48.3%	Shares	Defined	2026-08-12
2026-03-31	$27,346	714	-44.9%	Shares	Defined	2026-05-11
2025-12-31	$34,098	1,297	-39.8%	Shares	Defined	2026-02-12
2025-09-30	$30,147	2,155	+586.3%	Shares	Defined	2025-11-03
2025-06-30	$3,004	314	-33.9%	Shares	Defined	2025-08-13
2025-03-31	$4,417	475	-53.8%	Shares	Defined	2025-05-08
2024-12-31	$14,289	1,028	+10.5%	Shares	Defined	2025-02-13
2024-09-30	$21,864	930	+64.3%	Shares	Defined	2024-11-13
2024-06-30	$9,050	566	-20.6%	Shares	Defined	2024-08-08
2024-03-31	$11,693	713	-65.6%	Shares	Defined	2024-05-14
2023-12-31	$28,669	2,070	+1244.2%	Shares	Defined	2024-01-31
2023-09-30	$2,120	154	-95.0%	Shares	Defined	2023-11-13
2023-06-30	$52,196	3,065	+5575.9%	Shares	Defined	2023-08-14
2023-03-31	$867	54	—	Shares	Defined	2023-05-08
No filing history on record for this holder in this stock.